No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic*
-
Eligibility Determination / trends*
-
Humans
-
Neoplasms / drug therapy*
-
Patient Safety
-
Patient Selection*
-
Research Design / trends*
-
Risk Assessment